TGF-β1/FGF-2 signaling mediates the 15-HETE-induced differentiation of adventitial fibroblasts into myofibroblasts by unknown
RESEARCH Open Access
TGF-β1/FGF-2 signaling mediates the
15-HETE-induced differentiation of
adventitial fibroblasts into myofibroblasts
Li Zhang1, Yan Chen2, Guixia Li1, Minggang Chen1, Wei Huang1, Yanrui Liu1 and Yumei Li1,3*
Abstract
Background: Pulmonary adventitial fibroblasts (PAFs) are activated under stress stimuli leading to their
differentiation into myofibroblasts, which is involved in vessel remodeling. 15-HETE is known as an important factor
in vessel remodeling under hypoxia; however, the role of 15-HETE in PAF phenotypic alteration is not clear.
Results: The effect of 15-HETE on PAF phenotypic alterations was investigated in the present study. PAFs were
treated with 15-HETE (0.5 μM) for 24 h, and the myofibroblast marker α-smooth muscle actin (α-SMA) was analyzed.
The 15-HETE induced α-SMA expression and cell morphology. 15-HETE upregulated FGF-2 levels in PAFs, and
knockdown FGF-2 by siRNAs blocked the enhanced α-SMA expression induced by 15-HETE. p38 kinase was
activated, and blocked depressed 15-HETE-induced FGF-2 expression. The downstream of p38 pathway, Egr-1
activation, was also raised by 15-HETE treatment, and silenced Egr-1 suppressed the 15-HETE-induced upregulation
of FGF-2. TGF-β1 was upregulated with FGF-2 treatment, and α-SMA expression induced by FGF-2 was inhibited
after the cell was transferred with TGF-β1 siRNA. Meanwhile, FGF-2 increased α-SMA expression and improved
proliferation, which was associated with p27kip1 and cyclin E variation.
Conclusions: The above results suggest that p38/Egr-1 pathway-mediated FGF-2 is involved in 15-HETE-induced
differentiation of PAFs into myofibroblasts and cell proliferation.
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Background
Pulmonary vasculature remodeling is the main characteris-
tic of pulmonary artery hypertension (PAH), secondary to
chronic obstructive pulmonary disease (COPD) or intersti-
tial lung diseases. Vessel remodeling includes the alterations
in the intima, media, and adventitia of the pulmonary artery
[1, 2]. Hypoxia is the pathological basis of pulmonary vas-
cular remodeling, especially in the adventitia. It is recog-
nized as the earliest and most prominent structural change
during the PAH process [3]. Previous reports indicate that
15-hydroxyeicosatetraenoic acid (15-HETE), one of the
most important metabolic products of arachidonic acid
(AA) catalyzed by 15-lipoxygenase, is a novel molecule
involved in many cellular processes, including cell prolifera-
tion, fibrosis, migration, and inflammation [4]. In response
to hypoxia, adventitial fibroblast (PAF) is activated and
undergoes phenotypic changes, which is followed with pro-
liferation, differentiation, upregulation of contractile and
extracellular matrix proteins, and a release of factors that
directly affect medial smooth muscle cell tone and growth.
PAF transformation is thought to be the key step of
hypoxia-induced pulmonary vascular remodeling [5]. 15-
HETE induced vascular PAF migration through the activa-
tion of STAT3 and stimulated vascular adventitial fibrosis
via p38 MAPK-dependent TGF-β1 pathway were clarified
by our previous studies [6, 7]. We also identified 15-HETE-
induced differentiation of PAF into myofibroblast; however,
how and why this happened remains unclear. Thus, we aim
to explore the mechanism for 15-HETE-induced PAF
phenotypic alteration in this study.
In hypoxia-induced pulmonary hypertension, the early
and dramatic increase in the appearance of α-SMA in
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the adventitia is observed [8]. α-SMA is the most fre-
quently used marker for myofibroblast identification,
and the expression of α-SMA in the adventitial vessel
wall is a significant signal of fibroblast differentiations
into myofibroblast [9, 10]. Myofibroblasts accumulation
contributes to the changes in vascular tone and structure
under pathophysiological situations. Myofibroblasts are
also the most important producers of collagen, fibronec-
tin, tenascin, and elastin in the fibrotic tissues in re-
sponse to change in the local environment. Thus,
myofibroblasts are implicated as key participants in pul-
monary vascular remodeling [11].
The stiffening of the pulmonary adventitial layer is
recognized as the most sensing response when pul-
monary arteries undergo hypoxia. Activation of some
growth factors, with subsequent stimulation of protein
kinase C and mitogen activated protein (MAP) kinase
family members as well as phosphatidylinositol 3-
kinase (PI3K), are important regulators of hypoxia-
induced PAF proliferation [12]. Some potent media-
tors in response to earlier hypoxia have been
established by a variety of hypotheses. FGF-2 is one
of the most interesting growth factors among those
regulators such as ET-1, TGF-β, and PDGF. FGF-2
belongs to the fibroblast growth factor family. It is a
key player in the process of cell proliferation and dif-
ferentiation under various stimuli. FGF-2 mediated
cell phenotypic changes and increased nuclear p27kip1
and FoxO3a through PI3K-Akt and ERK pathways
during hypoxia-induced vascular remodeling [13].
Excessive proliferation and migration of PAFs
greatly contributed to the pathobiology of PAH [14].
The myofibroblasts could migrate from the adventitia
to the media or even the intima, leading to vessel
thickening. Myofibroblast accumulation in the intima
of arteries has been well documented and is consist-
ently observed accompanying hypoxia in PAH patients
[15]. However, where these proliferative cells originate
from and who mediates the process is unclear. Here
we intend to study the role of 15-HETE in PAF pro-
liferation and cell phenotypic changes, further explor-




15-HETE was purchased from Cayman Chemicals
(Ann Arbor, MI), Anti-phospho-p38, anti-p38, cyclin
E, FGF-2, α-SMA, TGF-β1 and GAPDH were pur-
chased from Santa Cruz Biotechnology (Santa Cruz,
CA). FGF-2 and Egr-1 siRNAs, FGF-2 and SP600125
were obtained from Sigma, USA. siRNA oligo was
synthesized by GenePharma Co., Ltd (Shanghai,
China).
Cell culture
Adventitia from the main pulmonary artery was
harvested from fresh rat lung. The pulmonary artery tis-
sue was carefully dissected free of blood vessels and fat
under a dissecting microscope, as previous described [6,
7]. Muscular tissue and endothelial cell layers were re-
moved by gentle abrasion of the vessel. The remaining
tissue (adventitia) was then dissected into 1 mm2 por-
tions. The portions of tissue were evenly distributed over
the base of a 25 cm2 culture flasks containing 2 ml of
Dulbecco’s modified eagle medium (DMEM) with 20 %
fetal bovine serum (FBS). The explants were incubated
in a humidified atmosphere with 5 % CO2 at 37 °C.
Fibroblast cells grew from the plants in about 5 days.
They were passaged and cultured in 15 % FBS. The 2 to
5 passages were used for the following experiments.
MTT
PAFs were cultured in a 96-well culture plate (about 1 ×
104), and then the cells were transferred with siR15-LO,
siRp27kipl or siRNC in DMEM with 5 % FBS. Then the
samples were exposed to hypoxia (3 % O2). Cinnamyl-
3,4-dihydroxy-a’-cyanocinnamate (CDC) or SP600125 at
the indicated concentrations were added under hypoxic
condition. At the end of the incubation in 37 °C, the
cells were incubated for 4 h in a medium containing
0.5 % 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazo-
lium bromide (MTT), the yellow mitochondrial dye. The
amount of blue formazan dye formed from MTT is pro-
portional to the number of surviving cells. The reaction
was terminated by adding DMSO to the medium
followed by incubation for 10 min. The spectrophotom-
eter absorbance at 540 nm was measured.
Cell transient transfection
To instigate the knockdown of p27kip1, the PAFs were
transfected with small interfering RNA, which was de-
signed and synthesized by GenePharma using X-treme
Gene siRNA Transfection Reagent (Roche Applied Sci-
ence, Mannheim, Germany). FAM-tagged non-targeted
control siRNA (siRNC) was used to examine and
optimize the efficiency of transfection and acted as a
negative control. The sense sequences of siRNA and α







PAFs were starved with DMEM without serum for
24 h before treatment. 10 μl X-tremeGene siRNA Trans-
fection Reagent were diluted in 90 μl serum-free Opti-
MEM-1 medium for 5 min, and 7.5 μl siRNA was
Zhang et al. Lipids in Health and Disease  (2016) 15:2 Page 2 of 8
diluted with 92.5 μl serum-free Opti-MEM-1 medium,
respectively. Then the two above mixtures were mixed
for another 20 min at RT. Changed the cell medium for
DMEM and added the siRNA and Transfection Reagent
mixtures to the cells for 6 h. Cells incubated with siRNC
in the same process served as controls. The transfected
medium was discarded and cells were cultured in
DMEM containing 5 % FBS under normal or 15-HETE
stimulation for 24 h. Protein contents were checked with
Western blot.
Immunofluorescence study and microscopic observation
PAFs were cultured on a poly-L-lysine-coated cover glass
(15 mm diameter) and washed three times with PBS,
followed by fixation with 4 % paraformaldehyde at room
temperature (RT) for 15 min. After permeabilization
with 0.1 % Triton X-100 for 15 min, the cells were
blocked with 3 % normal goat serum at RT for 30 min,
followed by incubation with anti-α-SMA primary anti-
bodies (1:100) in PBS at 4 °C overnight. After being
washed three times with PBS, the cells were incubated
with FITC-conjugated secondary antibody (1:100) di-
luted by PBS at RT for 2 h and DAPI away from light.
Then the cover glass was mounted and examined with
the Live cell station (DMI6000B, Leica, Germany).
Western blot
For Western blot analysis, total proteins were extracted
with 400 μl lysis buffer (Tris 50 mM, pH 7.4, NaCl
150 mM, Triton X-100 1 %, EDTA 1 mM, and PMSF
2 mM) and cleaved for 30 min on ice. Then the lysates
were centrifuged at 13,500 rpm for 10 min at 4 °C, and
the supernatant was collected. The protein concentra-
tion in the supernatant was determined by the bicincho-
ninic acid protein assay (Pierce, Rockford, IL) with
bovine serum albumin (BSA) as a standard. 50 μg pro-
teins of each sample were fractionated on a 10 % SDS-
polyacrylamide gel. After being electrophoretically trans-
ferred to a Pure Nitrocellulose Blotting membrane (Pall
Life Science), the membranes were incubated in a block-
ing buffer (Tris 20 mM, pH 7.6, NaCl 150 mM, and
Tween 20 0.1 %) containing 5 % nonfat dry milk powder,
and then the blots were probed with primary antibodies
overnight at 4 °C, with GAPDH as an internal control.
The immunoreactivity was detected using an enhanced
chemiluminescence (ECL) and then exposed to X-ray
film in a darkroom. Immunoblots were scanned using a
V330 densitometer and protein bands were quantified
with Quantity One software (EPSON, Bio-Rad Labora-
tories, Hercules, CA).
Statistical analysis
All data is presented as mean ± SEM. There are more
than two groups of continuous variables in this study, so
an one-way analysis of variance ANOVA followed by
Bonferroni or Dunnett’s post-hoc test was used for mul-
tiple comparisons. A two-tailed value of p < 0.05 is con-
sidered a statistically significant difference. Data is
analyzed using the GraphPad Prism 5.0 and SPSS 14.0.
Results
15-HETE induces PAF phenotypic changes
Adventitial fibroblasts differentiate into myofibroblast
phenotype under 15-HETE stimulation as our previous
studies reported. α-SMA, the most frequently used
marker for myofibroblast identification was studied.
PAFs were treated with 15-HETE (0.5 μM) for 24 h. As
shown in Fig. 1a, cells in the presence of 15-HETE, α-
SMA protein levels were significantly increased. Mean-
while, immunofluorescent staining also showed 15-
HETE increased α-SMA levels in PAFs (Fig. 1b).
FGF-2 was involved in 15-HETE-induced cell phenotypic
alterations
The differentiation of fibroblasts into myofibroblasts is
regulated by a complex microenvironment consisting of
growth factors, cytokines, adhesion molecules, and ECM
molecules. To examine whether FGF-2 is involved in 15-
HETE-induced PAF phenotypic changes, we determined
the FGF-2 expression after 15-HETE exposure through
immunoblotting. The results showed 15-HETE exposure
significantly increased FGF-2 levels (Fig. 2a). Further-
more, silencing FGF-2 with RNAi technique, α-SMA
expression was low in cells transfected with siRFGF
(Fig. 2b). The efficiency of FGF-2 silence was validated,
and silenced FGF-2 also decreased the α-SMA expres-
sion without 15-HETE exposure (Fig. 2c). These results
suggest that 15-HETE-induced phenotypic conversion of
fibroblasts into myofibroblasts was mediated by FGF-2
through detecting α-SMA expression levels.
15-HETE-induced FGF-2 upregulation requires p38 MAPK
PAFs were treated with 15-HETE, p38 MAPK and its
downstream target Egr-1 activity was analyzed. As
shown in Fig. 3a & b, both p38 and Egr-1 phosphoryl-
ation levels were raised by 15-HETE stimulation. To de-
termine the effect of p38 on 15-HETE increased FGF-2
expression in PAFs, a pharmacological inhibitor was
used. SB203580, an inhibitor of p38 kinase, blocked 15-
HETE induced FGF-2 upregulation (Fig. 3c). Egr-1 was
able to improve the promoter activity of FGF-2 as
reported [16]. So we performed a knockdown of Egr-1,
then cells were treated with 15-HETE, and we found
that FGF-2 expression was resumed to the control levels
(Fig. 3d).
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FGF-2-induced α-SMA expression is mediated by TGF-β1
TGF-β1 is a well-known cytokine capable of inducing
the transition of a fibroblast into a myofibroblast pheno-
type by stimulating α-SMA expression and collagen pro-
duction [28]. We performed immunoblotting directly for
TGF-β1 expression after the cells were treated with
FGF-2. Figure 4a showed that FGF-2 exposure (4 h) sig-
nificantly upregulates the level of TGF-β1 protein in
PAFs. To evaluate whether the increase in α-SMA ex-
pression induced by FGF-2 is dependent on TGF-β1,
PAFs were transiently transfected with TGF-β1 siRNA,
and then stimulated with FGF-2. We found TGF-β1
knockdown inhibited FGF-2-induced α-SMA increments
in PAFs (Fig. 4b).
FGF-2 induces α-SMA expression and cell proliferation
FGF-2-induced α-SMA expressions were assessed by im-
munoblotting and immunofluorescent staining, the re-
sults revealing that FGF-2 upregulated α-SMA levels
(Fig. 5a & b). As the transformation of fibroblasts into
myofibroblasts always occurs concomitantly with prolif-
eration, we detected the cell viability and cyclin E
changes after FGF-2 stimulation. We found that FGF-2
exposure significantly increased cell viability and cyclin
E expression in PAFs (Fig. 5c & d).
p27kip1 is known inhibitor for cell cycle G1/S transi-
tion, and is related to cell proliferation. Therefore, we
measured p27kip1 levels in FGF-2 treated cells in order
to infer the role it plays in cell viability and cyclin E
Fig. 1 15-HETE induced PAF phenotypic changes. PAFs were incubated with 15-HETE (0.5 μM) for 24 h. Subsequently myofibroblast markers,
α-SMA protein expression, was determined as a percentage of the untreated controls using Western blot (a) and (b). The characteristics of
myofibroblasts was assayed by immunocytochemistry staining; the nuclei was stained with 4′,6-diamidino-2-phenylindole (DAPI). Magnification:
200X. Data consists of the means of three independent experiments ± SEM (n = 3). * p < 0.05 vs. controls
Fig. 2 FGF-2 was involved in 15-HETE-induced cell phenotypic alterations. Cells were treated with 15-HETE (0.5 μM) for 24 h. a Western blot for
FGF-2 expression. b Cells were transferred with FGF-2 siRNAs, α-SMA was analyzed by Western blot. c The efficiency of FGF-2 silence and its
effects on α-SMA without 15-HETE treatments were validated. Data consists of the means of three independent experiments ± SEM (n = 3).
* p < 0.05 vs. controls; +p <0 .05 vs. 15-HETE
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expression. Western blot analysis revealed that, com-
pared with the controls, there is a significant reduction
in p27kip1 levels after the PAFs’ exposure to FGF-2
stimulation (Fig. 5e). Moreover, transfection with p27kip1
siRNA, cell viability and cyclin E were further enhanced
in PAFs (Fig. 5f & g). This data suggests that FGF-2 initi-
ates both growth and differentiation signals simultan-
eously in PAFs.
Discussion
15-HETE is a metabolic product of AA catalyzed by
15-LO, and it plays a noteworthy role in the patho-
genesis of vessel wall diseases [17]. 15-HETE was re-
ported to stimulate VSMC and PAEC proliferation
and apoptosis, thus contributing to hypoxia induced
pulmonary artery remodeling. Our previous studies
also indicated that 15-HETE induced PAF migration
and mediated the adventitial fibrosis in the early stage
of PAH in vivo [4, 6, 7]. Recently, more and more
evidence shows that fibroblasts could differentiate
into myofibroblasts under hypoxia, which could be
critical to hypoxia-induced pulmonary vascular re-
modeling [18]. However, whether 15-HETE was in-
volved in this pathological process is not clear. In the
present study, we investigated the effect of 15-HETE
on the PAF phenotypic alteration and explored the
underlying mechanisms. We found that 15-HETE up-
regulated the myofibroblast marker α-SMA, and the
FGF-2 expression. The blockage of FGF-2 by siRNA
or the inhibition of p38 MAPK relieved the upregula-
tion of α-SMA. Meanwhile, TGF-β1 was required for
15-HETE-induced α-SMA accumulation. Our study
indicates that 15-HETE was involved in the cell
phenotypic alteration of PAFs, and the TGF-β1
Fig. 3 15-HETE-induced FGF-2 upregulation requires p38 MAPK. Cells were treated with 15-HETE (0.5 μM) for 24 h. a Western blot for p38
phosphylation and total p38 levels, and p-Egr-1 expression (b). c Cells treated with p38 specific inhibitor, SB203580 (10 μM), or transfection with
Egr-1 siRNA (d), FGF-2 was analyzed using Western blot. Data consists of the means of three independent experiments ± SEM (n = 3). * p < 0.05 vs.
controls; +p < 0.05 vs. 15-HETE
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mediated FGF-2 signal pathways could be a novel tar-
get for pulmonary vascular adventitial remodeling.
Arterial walls are heterogeneous three-layered struc-
tures composed of the intima, media and adventitia [19].
Most studies focus on the endothelial cells and smooth
muscle cells (SMC), the principal cellular constituents of
the intima and media. Recently, the concept that the
vascular adventitia acts as a biological processing center
for the regulation of vessel wall function is rapidly emer-
ging, and much more attention is paid to the adventitia
and PAFs [20]. In the early stage of PAH, the adventitia
is much more sensitive to the environmental stresses
such as hypoxia, rapidly expressing and recruiting pro-
teins/factors which perpetuate the inflammatory re-
sponse. They increase the expression of contractile and
extracellular matrix (ECM) protein, differentiating into
SM-like cells, which can migrate to the inner layer with
greater propensity of proliferation. Meanwhile, the
phenotypic alteration and proliferative PAFs synthesize
and release inflammatory chemokines and neovascular
growth factors, further promoting the vascular angiogen-
esis and remodeling [21]. In brief, the contribution of
adventitial fibroblast phenotype changes to the PAH vas-
cular remodeling cannot be overlooked.
TGF-β1 and FGF-2 are responsible for the pheno-
typic changes in the activated PAFs. They are the
well-known cytokines capable of inducing fibroblast
transition into the myofibroblast phenotype by stimu-
lating α-SMA expression and collagen production
[22]. It is believed that in hypoxia induced pulmonary
vascular remodeling, TGF-β1 and FGF-2 mediate the dif-
ferentiation of fibroblasts from proliferative phenotype
into collagen-production and then into myofibroblastic
phenotypes [23]. TGF-β1 induced the isoform switching
of fibroblast growth factor (FGF) receptors, causing the
cells to become sensitive to FGF-2. FGF-2 is a type of
heparin-binding growth factor affecting the proliferation
of cells, driving the differentiation of PAFs into myofibro-
blast through the MAPK and extracellular ERK1 and
ERK2 pathways [24]. In the present study, 15-HETE
increased the expression of FGF-2 and α-SMA expression.
Meanwhile FGF-2 induced upregulation of α-SMA can be
blocked by the inhibition of TGF-β1. This data correlated
well with our previous studies, indicating that 15-HETE
promoted the proliferation of PAFs by the activation of
TGF-β1.
The proliferation of PAFs originating in “smooth
muscle-like cells” plays a key role in the early stage
of cell migration and vessel remodeling. The role of
15-HETE in proliferation of myofibroblast remains
unclear. p27kip1 is a kind of CDK inhibitor different
from the p53 or p16. p27kip1 negatively regulates the
cell cycle through the inhibition of cyclin enzyme
activity, preventing the cells’ G1/S phase transition,
and contributes to depressing the cell proliferation
[25]. Cyclin E, a regulation actor of CDK2 subunits,
mediates the cell cycle G1/S transition. We found
that 15-HETE induced the abnormal expression of
p27kip1, which may lead to G1/S conversion disorder
[26]. However, no reports showed the relationship
between p27kip1 and cell phenotypic alterations in
PAFs. This is the first observation in our present
study that 15-HETE increased cyclin E expression
through inhibiting p27kip1 in PAFs. This indicates that
Fig. 4 FGF-2-induced α-SMA expression is mediated by TGF-β1. Cells were treated with FGF-2 (15 ng/ml) for 4 h. a Western blot for TGF-β1
expression. b Cells transferred with TGF-β1 siRNAs, α-SMA changes were analyzed. Data consist of the means of three independent experiments
± SEM (n = 3). * p < 0.05 vs. controls; +p < 0.05 vs. 15-HETE
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15-HETE induced PAF differentiation via the FGF-2/
TGF-β1 pathway.
Conclusions
In conclusion, our study suggests that 15-HETE con-
verted adventitial fibroblasts into myofibroblasts through
the TGF-β1-mediated FGF-2 signal pathway and stimu-
lated “smooth muscle-like” PAF proliferation based on
upregulation of cyclin E induced by p27kip1. Our study
showed the importance of 15-HETE in PAF cell pheno-
typic alteration and proliferation under hypoxic stimula-
tion, and it potentiated the therapy target of adventitial
remodeling in PAH.
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